Summary
We have studied eight adult atopic asthmatic patients in a randomized double-blind, placebo-controlled, cross-over trial in order to examine the effects of the 5 HT2 antagonist ketanserin on airways function (FEV1, FVC, V50(χ), and V25(π)).
Ketanserin did not significantly change resting bronchomotor tone. Treadmill exercise caused a similar maximal percentage fall in FEV1 after both drug [16.8 (3.7)%] and placebo [19.2 (4.2)%]; ketanserin did not significantly attenuate bronchoconstriction, measured over a 20-min period after exercise.
These results suggest that 5 HT2 receptors do not play a major role in the control of resting bronchomotor tone or in exercise-induced bronchoconstriction in adult atopic asthmatic patients.
References
Barnes PJ, Ind P, Dollery CT (1981) Inhaled prazosin in asthma. Thorax 36: 378–381
Cazzola M, D'Amato G, Lobefalo G, Guillaro B, Sepe J, Assogna G, Pietroletti R, Lauria D (1987) Ketanserin, a new blocking agent of serotonin S2-receptors. Respiratory functional effects in chronic obstruction of the airways. Chest 92: 863–866
Cohen ML, Schenck KW, Colbert W, Wittenauer L (1985) Role of 5-HT2 receptors in serotonin-induced contractions of non-vascular smooth muscle. J Pharm Exp Ther 232: 770–774
Colebatch HJH, Olsen CR, Nadel JA (1966) Effect of histamine, serotonin, and acetylcholine on the peripheral airways. J Appl Physiol 21: 217–226
Cushley MJ, Lee WH, Holgate ST (1986) The effect of inhaled 5-hydroxytryptamine (5-HT, serotonin) on airway calibre in man. Br J Clin Pharmacol 22: 487–490
Da Prada M, Picotti GB (1979) Content and subcellular localisation of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: Monoamine distribution between platelets and plasma. Br J Pharmacol 65: 653–662
Davies CL (1983) Determination of ketanserin in plasma by reversed phase high performance chromatography. J Chromatogr 275: 232–233
De Clerck F, Xhonneux B (1985) Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in man. J Cardiovasc Pharmacol 7 [Suppl 7]: S23-S35
Donnelly R, Elliott HL, Meriedith PA, Reid JL (1987) Acute and chronic ketanserin in essential hypertension: Antihypertensive mechanisms and pharmacokinetics. Br J Clin Pharmacol 24: 599–606
Durham SR, Dawes J, Pepper DS, Lee TH, Kay AB (1984) Platelet function in exercise and allergen induced asthma. Thorax 39: 707
Hedner T, Pettersson A, Persson B (1986) Blood pressure reduction and pharmokinetics of ketanserin in hypertensive patients. J Hypertens 4 [Suppl 1]: S91-S93
Johnson CE, Davis S, Belfield PW, Cooke NJ, Davies JA (1984) Platelet activation during exercise induced asthma. Thorax 39: 706
Knauer KA, Lichtenstein LM, Adkinson NF Jr, Fish JE (1981) Platelet activation during antigen induced airway reactions in asthmatic subjects. N Engl J Med 304: 1404–1407
Leysen JA, Awouters F, Kennis L, Laduron PM, Vanderberk J, Janssen PAJ (1981) Receptor binding profile of R 41468, a novel antagonist at 5-HT receptors. Life Sci 28: 1015–1022
Robertson JIS, Stott DJ, Ball SG (1987) Antihypertensive mode of action of ketanserin. J Cardiovasc Pharmacol 10 [Suppl 3]: S45-S47
Saxena PR, Lawang A (1985) A comparison of the cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors. Arch Int Pharmacodyn Ther 277: 235–252
Sheller JR, Holtzman MJ, Skoogh B, Nadel JA (1982) Interaction of serotonin with vagal- and ACh-induced bronchoconstriction in canine lungs. J Appl Physiol 52: 964–966
So SY, Lam WK, Kwan S (1985) Selective 5-HT2 receptor blockade in exercise-induced asthma. Clin Allergy 15: 371–376
Thomson NC, Daniel EE, Hargreave FE (1982) Role of smooth muscle alpha receptors in non-specific bronchial responsiveness in asthma. Am Rev Respir Dis 126: 521–525
Tonnesen P (1985) Bronchial challenge with serotonin in asthmatics. Allergy 40: 136–140
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stott, D.J., Roberts, J.A., Thomson, N.C. et al. The effects of the 5 HT2 antagonist ketanserin in adult atopic asthma. Eur J Clin Pharmacol 35, 209–212 (1988). https://doi.org/10.1007/BF00609255
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609255